Insulin Injections for Type 2s Could Drop to Three per Week

Daily Injection

| Aug 1, 2011

A study in the British medical journal The Lancet shows that type 2s who received once-daily or thrice-weekly injections of degludec, a very long-acting insulin, maintained blood glucose levels similar to patients receiving daily doses of insulin glargine. The results point the way to a possible reduction in the number of injections that type 2s who take insulin would need over any seven-day period. In both the United States and the United Kingdom currently, about one in every three type 2 patients injects insulin at least once daily.

Researchers at the Mayo Clinic College of Medicine in Rochester, Minnesota, studied 245 type 2s who had not previously taken insulin as part of their therapy. Two-thirds of the study group took degludec, either once daily or three times weekly. The remaining participants took a daily injection of glargine, a long-acting basal insulin analog.

Blood sugar control levels across the three groups were similar, the study said. One major difference among the groups was that the daily degludec users experienced fewer incidences of hypoglycemia, the low blood sugar condition that can cause death in extreme cases.

If approved for sale in the United States, degludec would allow users to go 40 hours between injections, which is from 14 to 22 hours longer than they can with such current long-acting basal insulins as glargine or detemir.

The drug can also be mixed with other insulins, something that other long-acting insulins cannot do. Novo Nordisk, the insulin's developer, is hoping to reach the market by 2013.

Click Here To View Or Post Comments

Categories: Blood Glucose, Diabetes, Diabetes, Insulin, Insulin Injection, Type 2 Issues


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.